Semax – 10mg | Research Compound

Semax | Research Compound

Semax is a synthetic heptapeptide research compound derived from the ACTH(4-10) fragment, with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is studied in laboratory settings for its molecular characteristics, gene-expression activity, and interactions with cellular signaling pathways.

Key Research Areas:

• Gene-Expression Research — Laboratory investigation of gene-expression patterns associated with Semax.
• BDNF-Related Research — Investigation of Semax in relation to BDNF-associated molecular signaling pathways.
• Receptor Signaling Research — Laboratory characterization of receptor-associated signaling and molecular interactions.
• Cellular Signaling Research — Investigation of intracellular signaling processes associated with Semax.
• Molecular Pathway Research — Laboratory investigation of downstream molecular processes and signaling pathways.

Product Specifications:

• Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
• Seven-amino-acid research compound
• Molecular Formula: C₃₇H₅₁N₉O₁₀S
• Molecular Weight: ~813.0 g/mol
• 10mg lyophilized powder per vial
• ≥99% purity via HPLC and mass spectrometry
• Third-party COA available
• Store according to applicable laboratory storage requirements and protect from light and moisture

For laboratory and research use only. Not intended for human or animal consumption, administration, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic. Not FDA-approved.